Author

D. van der Woude

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:differential expression· 1 Assay:flow cytometry· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

H. U. Scherer· 2 shared A. H. M. van der Helm-van Mil· 1 shared A. Kawakami· 1 shared D. van Schaardenburg· 1 shared H. El-Gabalawy· 1 shared J. C. Kwekkeboom· 1 shared J. Suurmond· 1 shared L. Hafkenscheid· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

H. U. Scherer

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Autoreactive B cells in rheumatoid arthritis consist of activated CXCR3+ memory B cells and plasmablasts

S. Reijm, J. C. Kwekkeboom, N. J. Blomberg, J. Suurmond, D. van der Woude, R. E. Toes, H. U. Scherer

The paper identifies CXCR3+ memory B cells and plasmablasts as autoreactive B cells in rheumatoid arthritis, showing cross-reactivity against PTM antigens and high CXCR3 expression.

bioRxiv · May 19, 2023 · PreprintImmunology

ACPA-IgG variable domain glycosylation increases before the onset of rheumatoid arthritis and stabilizes thereafter; a cross-sectional study encompassing over 1500 samples

T. Kissel, L. Hafkenscheid, T. J. van Wesemael, M. Tamai, S.-y. Kawashiri, A. Kawakami, H. El-Gabalawy, D. van Schaardenburg, S. Rantapaa Dahlqvist, M. Wuhrer, A. H. M. van der Helm-van Mil, R. Allaart, D. van der Woude, H. U. Scherer, R. E. M. Toes, T. W. J. Huizinga

This study shows ACPA-IgG variable domain glycosylation increases before rheumatoid arthritis onset and stabilizes later, with lower levels at onset correlating with drug-free remission.

bioRxiv · Nov 5, 2021Immunology